Clinical Trial Update: Target Engagement of EXL01 in the Prevention of Post-operative Recurrence of Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating EXL01 for preventing postsurgical recurrence in Crohn's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• EXL01

Snippet

Sponsor: Madeleine Bezault | Conditions: Crohn Disease (CD) | Phase 2 | Status: RECRUITING